UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Cleveland BioLabs is implementing good security practices.
Cleveland BioLabs, Inc. (Nasdaq: CBLI) is a clinical-stage biotechnology company with a focus on oncology development.
This report shows a preliminary security rating for Cleveland BioLabs. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.Get a deeper scan →
Read more about the latest issues in cybersecurity
Confidentiality, integrity and availability (the CIA triad) is a security model that guides ...
For many businesses, global third-party vendors have become an important source of strategic ...
Compare Cleveland BioLabs's security performance with other companies